PRESIDENT TRUMP left Washington Monday boosted by a pause in the trade war with China but trailed by a new controversy over ...

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

The Trump administration issued a proposal Monday that would tighten regulations that govern supplemental income streams that ...

President Donald Trump signed an executive order May 12 directing drugmakers to sell medicines in the U.S. at prices similar to those offered in other wealthy countries, or face penalties and ...

Health policy experts said it is still unclear how much prices will go down, which medicines will be impacted and whether the ...

This past week, I visited Capitol Hill in Washington, D.C. to speak with our congressional delegates and attend the American ...

Reps. Jack Bergman (R-Mich.) and Lou Correa (D-Calif.), who co-chair the Congressional Psychedelic Advancing Therapies Caucus, seek a meeting in light of Collins’ recent promotion of the drug therapy.

Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other ...

President Donald Trump said he plans to sign an executive order on May 12 aimed at reducing the cost of some medications, according to a May 11 Truth Social post. The order would direct HHS to align ...

The proposal would see the HHS set price targets other countries pay for certain medicines, kicking off a round of ...

House Republicans are proposing work requirements for Medicaid and are planning to limit states’ use of the lucrative ...